court case:https://www.financemagnates.com/institutional-forex/exchanges/isignthis-seeks-initial-damages-of-27-million-from-asx/
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%